204 related articles for article (PubMed ID: 30652209)
1. Blastic plasmacytoid dendritic cell neoplasm with response to pralatrexate.
Sato S; Tanaka E; Tamai Y
Ann Hematol; 2019 Mar; 98(3):801-803. PubMed ID: 30652209
[No Abstract] [Full Text] [Related]
2. Case of blastic plasmacytoid dendritic cell neoplasm.
Aoi J; Ogata A; Makino T; Sakai K; Masuguchi S; Fukushima S; Jinnin M; Inoue Y; Ihn H
J Dermatol; 2012 Dec; 39(12):1066-7. PubMed ID: 22970734
[No Abstract] [Full Text] [Related]
3. Lacking CD56 expression in a relapsing cutaneous blastic plasmacytoid dendritic cell neoplasm after allogeneic bone marrow transplantation: FISH analysis revealed loss of 11q.
Mitteldorf C; Bertsch HP; Baumgart M; Haase D; Wulf G; Schön MP; Rosenwald A; Neumann C; Kaune KM
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1225-9. PubMed ID: 21923812
[TBL] [Abstract][Full Text] [Related]
4. [Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic study].
Sang W; Wang CF; Cheng YF; Liu X; Li XX; Gulinar A; Li JZ; Zhang W
Zhonghua Bing Li Xue Za Zhi; 2012 May; 41(5):326-30. PubMed ID: 22883672
[TBL] [Abstract][Full Text] [Related]
5. Two rare cases of blastic plasmacytoid dendritic cell neoplasm and a literature review.
Chu G; Verner E; Lee K; Painter V; Fletcher J; Curnow J
Leuk Lymphoma; 2014 Oct; 55(10):2405-7. PubMed ID: 24432892
[No Abstract] [Full Text] [Related]
6. Blastic plasmacytoid dendritic cell neoplasm.
Munoz J; Rana J; Inamdar K; Nathanson D; Janakiraman N
Am J Hematol; 2012 Jul; 87(7):710. PubMed ID: 21953644
[No Abstract] [Full Text] [Related]
7. Sustained complete remission of a limited-stage blastic plasmacytoid dendritic cell neoplasm followed by a simultaneous combination of low-dose DeVIC therapy and radiation therapy: a case report and review of the literature.
Sugimoto KJ; Shimada A; Yamaguchi N; Imai H; Wakabayashi M; Sekiguchi Y; Izumi H; Ota Y; Komatsu N; Noguchi M
Int J Clin Exp Pathol; 2013; 6(11):2603-8. PubMed ID: 24228127
[TBL] [Abstract][Full Text] [Related]
8. Safety and effective salvage regimen comprising a novel combination of brentuximab vedotin, L-asparaginase, and dexamethasone for refractory anaplastic large cell lymphoma, anaplastic lymphoma kinase negative.
Kawamoto K; Suzuki T; Kasami T; Kiryu M; Sone H; Miyoshi H; Ohshima K; Takizawa J
Hematol Oncol; 2019 Apr; 37(2):212-214. PubMed ID: 30394560
[No Abstract] [Full Text] [Related]
9. Successful treatment of an elderly Langerhans cell sarcoma patient by EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin) chemotherapy.
Matsukawa T; Suto K; Miyoshi H; Oshimi K; Ohshima K; Miyagishima T
J Clin Exp Hematop; 2018 Dec; 58(4):184-187. PubMed ID: 30305476
[No Abstract] [Full Text] [Related]
10. Blastic Plasmacytoid Dendritic Cell Neoplasm: First Case Report From Rwanda and Review of the Literature.
Ruhangaza D; Mugabe MC; Kigonya CN; Lane AA; Morgan EA
J Glob Oncol; 2019 Jun; 5():1-6. PubMed ID: 31246550
[No Abstract] [Full Text] [Related]
11. Strong periodic acid-schiff reaction in hypervacuolated blastic plasmacytoid dendritic cell neoplasm.
Prats-Martín C; Morales-Camacho RM; Blum-Domínguez MA; Cabrera-Pérez R; Bernal R; Caballero-Velázquez T; Pérez-Simón JA
Diagn Cytopathol; 2016 Jan; 44(1):39-40. PubMed ID: 26467980
[No Abstract] [Full Text] [Related]
12. Blastic plasmacytoid dendritic cell neoplasm.
Lim D; Goodman H; Rademaker M; Lamont D; Yung A
Australas J Dermatol; 2013 May; 54(2):e43-5. PubMed ID: 23582004
[TBL] [Abstract][Full Text] [Related]
13. CD4+ CD56+ blastic tumor of the skin: cytogenetic observations and further evidence of an origin from plasmocytoid dendritic cells.
Hallermann C; Middel P; Griesinger F; Gunawan B; Bertsch HP; Neumann C
Eur J Dermatol; 2004; 14(5):317-22. PubMed ID: 15358570
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and treatment outcomes of blastic plasmacytoid dendritic cell neoplasm: a single-center experience in Korea.
Kim HS; Kim HJ; Kim SH; Choi JY; Ko YH; Kim WS; Jung CW; Kim SJ
Korean J Intern Med; 2017 Sep; 32(5):890-899. PubMed ID: 28870016
[TBL] [Abstract][Full Text] [Related]
15. [Plasmacytoid dendritic cell tumor].
Pérez-Crespo M; Moragón M; Onrubia J; Sevila A; Alfonso R; Miralles J; Requena L
Actas Dermosifiliogr; 2011 Apr; 102(3):229-31. PubMed ID: 21232729
[No Abstract] [Full Text] [Related]
16. Rituximab in combination with interferon-alpha in relapsed and refractory diffuse large B-cell non-Hodgkin's lymphoma.
Bertè R; Vallisa D; Civardi G; Moroni CF; Lazzaro A; Cavanna L
Acta Haematol; 2001; 106(3):141-2. PubMed ID: 11713384
[No Abstract] [Full Text] [Related]
17. Bilateral sciatic nerve neurolymphomatosis: PET/CT findings.
Gorospe L; Gallego-Rivera JI; Rioja-Martín ME; Chinea-Rodríguez A
Ann Hematol; 2017 Jun; 96(6):1059-1060. PubMed ID: 28374164
[No Abstract] [Full Text] [Related]
18. [Treatment of localized nasal NK/T-cell lymphoma].
Yamaguchi M
Rinsho Ketsueki; 2008 Aug; 49(8):553-8. PubMed ID: 18800601
[No Abstract] [Full Text] [Related]
19. Non-hodgkins lymphoma.
Mead G; Woodcock J; Young C
Clin Evid; 2003 Jun; (9):1-21. PubMed ID: 12967352
[No Abstract] [Full Text] [Related]
20. [Treatment strategy of gray zone lymphomas].
Maruyama D
Rinsho Ketsueki; 2014 Oct; 55(10):1912-9. PubMed ID: 25297755
[No Abstract] [Full Text] [Related]
[Next] [New Search]
